You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
北陸藥業(300016.SZ):“滄州三期原料藥生產項目”預計於2024年9月末達到預定使用狀態
格隆匯 07-17 16:52

格隆匯7月17日丨北陸藥業(300016.SZ)於2024年7月16日接受特定對象調研,就“滄州三期原料生產項目建設進度”,公司回覆稱,“滄州三期原料藥生產項目”預計於2024年9月末達到預定使用狀態。根據公司戰略規劃,滄州生產基地將建設為公司化學原料藥生產基地,因此滄州三期原料藥生產項目中,公司加大化學原料藥研發投入並建設相應生產車間,進一步豐富公司化學原料藥產品類別,以提升產品的多樣性,進一步提高公司的綜合競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account